The leading Oxford’s chimpanzee adenovirus vaccine platform has been engineered as a Zika vaccine, opening the door to clinical trials at the University of Oxford and Mexico. The development was published in Nature Communications in a multinational team effort lead by Prof. Arturo Reyes-Sandoval, the Jenner Institute (NDM) in collaboration with Imperial College London, University of Glasgow, Harvard Medical School, and the Oswaldo Cruz Foundation in Brazil.
Development of a highly protective Zika vaccine through modulation of antigen membrane anchors
Research
26 June 2018